216 related articles for article (PubMed ID: 26340055)
1. Epigenomic mapping and effect sizes of noncoding variants associated with psychotropic drug response.
Higgins GA; Allyn-Feuer A; Athey BD
Pharmacogenomics; 2015; 16(14):1565-83. PubMed ID: 26340055
[TBL] [Abstract][Full Text] [Related]
2. A glutamatergic network mediates lithium response in bipolar disorder as defined by epigenome pathway analysis.
Higgins GA; Allyn-Feuer A; Barbour E; Athey BD
Pharmacogenomics; 2015; 16(14):1547-63. PubMed ID: 26343379
[TBL] [Abstract][Full Text] [Related]
3. Enhancer variants associated with Alzheimer's disease affect gene expression via chromatin looping.
Kikuchi M; Hara N; Hasegawa M; Miyashita A; Kuwano R; Ikeuchi T; Nakaya A
BMC Med Genomics; 2019 Sep; 12(1):128. PubMed ID: 31500627
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide map of regulatory interactions in the human genome.
Heidari N; Phanstiel DH; He C; Grubert F; Jahanbani F; Kasowski M; Zhang MQ; Snyder MP
Genome Res; 2014 Dec; 24(12):1905-17. PubMed ID: 25228660
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide studies of CCCTC-binding factor (CTCF) and cohesin provide insight into chromatin structure and regulation.
Lee BK; Iyer VR
J Biol Chem; 2012 Sep; 287(37):30906-13. PubMed ID: 22952237
[TBL] [Abstract][Full Text] [Related]
6. Epigenome overlap measure (EPOM) for comparing tissue/cell types based on chromatin states.
Li WV; Razaee ZS; Li JJ
BMC Genomics; 2016 Jan; 17 Suppl 1(Suppl 1):10. PubMed ID: 26817822
[TBL] [Abstract][Full Text] [Related]
7. The epigenome, 4D nucleome and next-generation neuropsychiatric pharmacogenomics.
Higgins GA; Allyn-Feuer A; Handelman S; Sadee W; Athey BD
Pharmacogenomics; 2015; 16(14):1649-69. PubMed ID: 26338265
[TBL] [Abstract][Full Text] [Related]
8. Predicting regulatory variants using a dense epigenomic mapped CNN model elucidated the molecular basis of trait-tissue associations.
Pei G; Hu R; Dai Y; Manuel AM; Zhao Z; Jia P
Nucleic Acids Res; 2021 Jan; 49(1):53-66. PubMed ID: 33300042
[TBL] [Abstract][Full Text] [Related]
9. Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus.
Zhang X; Cowper-Sal lari R; Bailey SD; Moore JH; Lupien M
Genome Res; 2012 Aug; 22(8):1437-46. PubMed ID: 22665440
[TBL] [Abstract][Full Text] [Related]
10. Exploring the effects of genetic variation on gene regulation in cancer in the context of 3D genome structure.
Osman N; Shawky AE; Brylinski M
BMC Genom Data; 2022 Feb; 23(1):13. PubMed ID: 35176995
[TBL] [Abstract][Full Text] [Related]
11. Trans-Ancestral Fine-Mapping and Epigenetic Annotation as Tools to Delineate Functionally Relevant Risk Alleles at
Vyse TJ; Cunninghame Graham DS
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182226
[No Abstract] [Full Text] [Related]
12. Topologically associating domains and chromatin loops depend on cohesin and are regulated by CTCF, WAPL, and PDS5 proteins.
Wutz G; Várnai C; Nagasaka K; Cisneros DA; Stocsits RR; Tang W; Schoenfelder S; Jessberger G; Muhar M; Hossain MJ; Walther N; Koch B; Kueblbeck M; Ellenberg J; Zuber J; Fraser P; Peters JM
EMBO J; 2017 Dec; 36(24):3573-3599. PubMed ID: 29217591
[TBL] [Abstract][Full Text] [Related]
13. Interrogation of human hematopoiesis at single-cell and single-variant resolution.
Ulirsch JC; Lareau CA; Bao EL; Ludwig LS; Guo MH; Benner C; Satpathy AT; Kartha VK; Salem RM; Hirschhorn JN; Finucane HK; Aryee MJ; Buenrostro JD; Sankaran VG
Nat Genet; 2019 Apr; 51(4):683-693. PubMed ID: 30858613
[TBL] [Abstract][Full Text] [Related]
14. Interplay between CTCF boundaries and a super enhancer controls cohesin extrusion trajectories and gene expression.
Vos ESM; Valdes-Quezada C; Huang Y; Allahyar A; Verstegen MJAM; Felder AK; van der Vegt F; Uijttewaal ECH; Krijger PHL; de Laat W
Mol Cell; 2021 Aug; 81(15):3082-3095.e6. PubMed ID: 34197738
[TBL] [Abstract][Full Text] [Related]
15. Using 3D epigenomic maps of primary olfactory neuronal cells from living individuals to understand gene regulation.
Rhie SK; Schreiner S; Witt H; Armoskus C; Lay FD; Camarena A; Spitsyna VN; Guo Y; Berman BP; Evgrafov OV; Knowles JA; Farnham PJ
Sci Adv; 2018 Dec; 4(12):eaav8550. PubMed ID: 30555922
[TBL] [Abstract][Full Text] [Related]
16. Epigenomic and Transcriptomic Prioritization of Candidate Obesity-Risk Regulatory GWAS SNPs.
Zhang X; Li TY; Xiao HM; Ehrlich KC; Shen H; Deng HW; Ehrlich M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163195
[TBL] [Abstract][Full Text] [Related]
17. Bridging between Mouse and Human Enhancer-Promoter Long-Range Interactions in Neural Stem Cells, to Understand Enhancer Function in Neurodevelopmental Disease.
D'Aurizio R; Catona O; Pitasi M; Li YE; Ren B; Nicolis SK
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887306
[TBL] [Abstract][Full Text] [Related]
18. Strategies to fine-map genetic associations with lipid levels by combining epigenomic annotations and liver-specific transcription profiles.
Lo KS; Vadlamudi S; Fogarty MP; Mohlke KL; Lettre G
Genomics; 2014 Aug; 104(2):105-12. PubMed ID: 24997396
[TBL] [Abstract][Full Text] [Related]
19. IMPACT: Genomic Annotation of Cell-State-Specific Regulatory Elements Inferred from the Epigenome of Bound Transcription Factors.
Amariuta T; Luo Y; Gazal S; Davenport EE; van de Geijn B; Ishigaki K; Westra HJ; Teslovich N; Okada Y; Yamamoto K; ; Price AL; Raychaudhuri S
Am J Hum Genet; 2019 May; 104(5):879-895. PubMed ID: 31006511
[TBL] [Abstract][Full Text] [Related]
20. Context-dependent perturbations in chromatin folding and the transcriptome by cohesin and related factors.
Nakato R; Sakata T; Wang J; Nagai LAE; Nagaoka Y; Oba GM; Bando M; Shirahige K
Nat Commun; 2023 Sep; 14(1):5647. PubMed ID: 37726281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
